<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Context:Investigating the impact of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> on pancreatic <z:chebi fb="32" ids="24621">endocrine</z:chebi> function promotes our understanding of the pathophysiology of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>-related disease.Objective:The objective of the study was to test the hypothesis that experimental <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> impairs insulin and glucagon secretion.Design:A randomized, crossover in healthy controls, compared with type 2 diabetic patients.Setting:The study was conducted at a university hospital.Participants:<z:mpath ids='MPATH_458'>Normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant subjects (n = 10) and patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 10), individually matched by age, sex, and body mass index.Interventions:<z:mpath ids='MPATH_458'>Normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant subjects underwent 24 h of experimental <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (+5.4 mm above basal) </plain></SENT>
<SENT sid="1" pm="."><plain>Subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> did not undergo an intervention.Main Outcome Measures:Insulin secretion, glucagon secretion, insulin sensitivity, disposition index, and endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production (via [6,6-(2)H(2)]<z:chebi fb="105" ids="17234">glucose</z:chebi> infusion) were measured during hyperglycemic clamps combined with infusion of glucagon-like <z:chebi fb="7" ids="16670">peptide</z:chebi> (GLP)-1(7-36) (0.5 pmol/kg · min) and injection of arginine (5 g).Results:Insulin secretion was correlated with glucagon suppression in subjects with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance only </plain></SENT>
<SENT sid="2" pm="."><plain>Individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> had lower insulin sensitivity (-33 ± 11%) and insulin secretory responses to <z:chebi fb="105" ids="17234">glucose</z:chebi>, GLP-1, and arginine (-40 ± 11, -58 ± 7, and -36 ± 13%, respectively) and higher plasma glucagon and endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production compared with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant subjects (<z:hpo ids='HP_0000001'>all</z:hpo> P &lt; 0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>After 24 h of experimental <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, insulin sensitivity (-29 ± 10%), disposition index (-24 ± 16%), and GLP-1- (-19 ± 7%) and arginine-stimulated (-15 ± 10%) insulin secretion were decreased in <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant subjects (<z:hpo ids='HP_0000001'>all</z:hpo> P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>However, plasma glucagon responses were not affected </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, experimental <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> abolished the correlation between insulin secretion and glucagon suppression.Conclusions:Experimental <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> impaired pancreatic β-cell function but did not acutely impair α-cell glucagon secretion in <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant subjects </plain></SENT>
</text></document>